Cypress Capital Management (Wyoming)’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
– Hold
0
– -$3K – 377
2018
Q2
– Hold
0
– – – 311

Cypress Capital Management (Wyoming)'s AMPE Position: Q2 2026 in Review

Cypress Capital Management (Wyoming) sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q2 2026, closing a stake of 440 shares — an estimated $67 sold.

Cypress Capital Management (Wyoming) first reported a position in AMPE in Q4 2016 and held it in 35 quarters. The position peaked at $708K in Q2 2018. 0 funds tracked by Wall St. Rank hold AMPE as of Q2 2026.

  • Cypress Capital Management (Wyoming) reported no remaining Ampio Pharmaceuticals Inc. position as of Q2 2026 after selling out during the quarter.
  • Cypress Capital Management (Wyoming) sold 440 Ampio Pharmaceuticals Inc. shares in Q2 2026, an estimated $67.
  • Cypress Capital Management (Wyoming) first reported a position in Ampio Pharmaceuticals Inc. in Q4 2016 and held it in 35 quarters.
  • Cypress Capital Management (Wyoming)'s Ampio Pharmaceuticals Inc. position peaked at $708K in Q2 2018.
  • 0 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q2 2026.

Based on Cypress Capital Management (Wyoming)'s 13F filing for Q2 2026, filed 6 Aug 2026.